HTG Molecular Diagnostics (HTGM) Reports Q4 Loss of $0.76/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
HTG Molecular Diagnostics (HTGM) Set to Open Sharply Higher
March 24, 2017 6:45 AM EDTHTG Molecular Diagnostics (NASDAQ: HTGM) traded higher pre-market on Friday, rising over 50%. Yesterday it announced a CE mark for its HTG EdgeSeq ALKPlus Assay EU. It also announced Q4 earnings after the market close.
... More